Award
National Heart, Lung, and Blood Institute 11324593
SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS
Recipient
VENOSTENT, INC.
Award Amount
$1,212,392.00
Ceiling
$1,212,392.00
Awarded
May 19, 2026
Identifier
11324593
NIH awarded VENOSTENT, INC. a SBIR Phase II grant to develop and test a bioabsorbable wrap for vascular surgery in CKD patients, aiming for FDA approval.
Description
This is a NIH SBIR Phase II project focused on developing a bioabsorbable wrap to improve vascular surgery outcomes in CKD patients. The project aims to demonstrate safety and effectiveness in a pivotal trial for FDA approval. The award is from the National Heart Lung and Blood Institute (NHLBI).